Product Highlights

Pharmaceutical Products

Cancer

In oncology, Abbott scientists unveiled new clinical trial data pertaining to two potentially breakthrough molecules for the treatment of certain cancer types – ABT-263 (Bcl-2 inhibitor) and ABT-869 (multi-kinase inhibitor). Our Bcl-2 family protein antagonist is the first in a new class of drugs that attack cancer cells by seeking to trigger a “switch” in cancer cells, causing them to die.

Immunology

Abbott produced the first fully human recombinant monoclonal antibody approved by the FDA to treat rheumatoid arthritis, Crohn’s disease, psoriatic arthritis, and ankylosing spondylitis, or arthritis of the spine. In 2008, we received U.S. approval for moderate-to-severe chronic plaque psoriasis; and both U.S. and European Union (E.U.) approval, for our latest indication, polyarticular juvenile idiopathic arthritis.

Neuroscience

Abbott is building a pipeline of innovative treatments for Alzheimer’s disease and schizophrenia, diseases that impact millions of patients worldwide. We’re also pursuing compounds that could provide relief across a broad spectrum of pain-states, such as osteoarthritis, post-operative pain and cancer pain.

SOLIQS-Meltrex Formulation Technology

Abbott’s Meltrex technology is helping us develop new formulations of our medicines to benefit patients around the world, including a heat-stable tablet version of our leading HIV medicine. This new formulation eliminates the need for refrigeration and can be taken without food – important advances for patients in developing regions.

Diagnostics and Medical Devices

Vascular Care

In 2008, our drug-eluting stent was approved for use in the U.S. This device is used to prop open a narrowed or blocked artery and release a drug to prevent the artery from becoming blocked again.

Monitoring Diabetes

In 2008, we introduced the an easy-to-hold, easy-to-read blood glucose monitoring system that uses a small blood sample size, and features a 5-second-average test time. Abbott also launched a continuous glucose monitoring system provides glucose readings and trend information to allow people with diabetes to more proactively manage their disease.

Molecular Diagnostics

Abbott’s molecular diagnostics provide physicians with critical information for the effective diagnosis, treatment and monitoring of diseases. In 2008, we introduced a new testing protocol for the m2000 system for use in remote areas of the world. The protocol is designed to use dried blood spots deposited on absorbent filter paper, which allows patient samples to be collected in remote areas and mailed to regional laboratories for sophisticated analysis.

Nutrition Products

Abbott is committed to the nutritional health and well-being of children and families. We develop and manufacture a broad range of nutrition products, and we focus on innovative nutrition solutions – from ensuring babies have a strong start in life to addressing the nutritional and medical needs of adult patients. Abbott nutrition scientists have pioneered medical nutrition products for diabetic and cancer patients and are forerunners in critical care nutrition – including development of innovative infant formulas such as those specifically designed for pre-term infants.

As a leading manufacturer of infant formulas, we agree with medical and health organizations throughout the world that breastfeeding is the best form of infant nutrition and should be the first choice for babies. When an alternative to breastfeeding is necessary or chosen, we offer high-quality infant formulas and nutritional products and provide materials that help educate physicians, nurses, midwives and others on the latest breastfeeding information and advice, as well as materials that health care professionals can use to help new mothers and families learn the basics of infant nutrition and health care.

We comply with all relevant laws, regulations and promotional standards around the world. This includes adhering to principles of the International Code of Marketing of Breast Milk Substitutes where it has been implemented by governments.

Although more can be done to further support breastfeeding around the world, iron-fortified infant formula is the only safe, nutritious and recommended alternative when breast milk is not an option. Infant formula provides a superior alternative to less-healthy, home-based breast milk substitutes such as raw cow's milk or rice water.

For more information about Abbott's breastfeeding support and education programs in the United States: For more information about Abbott's breastfeeding support and education programs in the United States, please read:

Ensuring Optimal Infant Nutrition - A Shared Responsibility

Ensuring Optimal Infant Nutrition - Achieving Balance for Health Outcomes

Business Backs Breastfeeding - A Flexible Workplace Program for Breastfeeding Mothers